Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Astrocytes – cells that until only recently have been dismissed as merely brain “glue” – are becoming increasingly important and flexible tools in confronting a range of neurological disorders. New research shows that the right kind of astrocyte can restore order and rescue cells in brains ravaged by Parkinson’s disease.
1/29/2014 | 2 comments
When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.
1/28/2014 | 0 comments
Platelets are known for their role in forming blood clots, but more and more research shows that platelets help control our immune system as well. A study in The Journal of Clinical Investigation suggests a new way in which platelets influence our immune response that could alter the treatment of arthritis, asthma and atherosclerosis.
1/27/2014 | 0 comments
Research led by emergency medicine specialist Jeffrey Bazarian, M.D., M.P.H., was featured in the R&D section of last weekend’s Wall Street Journal.
1/20/2014 | 0 comments
A brain protein, S100B, which may soon be detected by a simple finger-stick blood test, accurately distinguishes a sports-related concussion from sports exertion, according to a study of college athletes in Rochester, N.Y., and Munich, Germany, and published in PLOS ONE by Jeffrey J. Bazarian, M.D, associate professor at the University of Rochester.
1/9/2014 | 1 comment